Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol dosing for severe hypertension in preeclampsia
NCT03877692Phase 4Terminated
- Sponsor
- Albany Medical College
- Start
- Feb 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of labetalol in preeclampsia, hypertension (HTN), sponsored by Albany Medical College. Started Feb 2019; status: terminated.
02
Drugs
labetalol
03
Conditions
preeclampsiahypertension (HTN)
Beyond the preview
Go deeper on NCT03877692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03877692.